Indication
Allergic bronchopulmonary aspergillosis
Allergic bronchopulmonary aspergillosis is a complex immunological pulmonary disorder characterized by a hypersensitivity response to colonization of the lower airways by *Aspergillus* species, primarily *Aspergillus fumigatus*. Read more about Allergic bronchopulmonary aspergillosis
99 drugs 74 manufacturers
Drugs that treat it
Common Allergic bronchopulmonary aspergillosis therapies.
PREDNISONE
PREDNISONE
PREDNISONE
PREDNISONE
PREDNISONE
PREDNISOLONE
PREDNISONE
PREDNISONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAllergic bronchopulmonary aspergillosis is a complex immunological pulmonary disorder characterized by a hypersensitivity response to colonization of the lower airways by *Aspergillus* species, primarily *Aspergillus fumigatus*.
It predominantly affects individuals with underlying chronic respiratory conditions, specifically asthma and cystic fibrosis.
Pathophysiologically driven by an exaggerated T-helper type 2 inflammatory reaction, the condition is clinically marked by recurrent wheezing, cough with brown mucus plugs, pulmonary infiltrates, peripheral blood and sputum eosinophilia, and elevated total and fungus-specific serum immunoglobulin E levels.
Without timely recognition, persistent airway inflammation can cause central bronchiectasis and irreversible fibrotic lung damage.
- nih.gov
Allergic bronchopulmonary aspergillosis is a complex immunological pulmonary disorder characterized by a hypersensitivity response to colonization of the lower airways by *Aspergillus* species, primarily *Aspergillus fumigatus* It predominantly affects individuals with underlying chronic respiratory conditions, specifically asthma and cystic fibrosis
- nih.gov
Allergic bronchopulmonary aspergillosis is a complex immunological pulmonary disorder characterized by a hypersensitivity response to colonization of the lower airways by *Aspergillus* species, primarily *Aspergillus fumigatus*
- nih.gov
It predominantly affects individuals with underlying chronic respiratory conditions, specifically asthma and cystic fibrosis Pathophysiologically driven by an exaggerated T-helper type 2 inflammatory reaction, the condition is clinically marked by recurrent wheezing, cough with brown mucus plugs, pulmonary infiltrates, peripheral blood and sputum eosinophilia, and elevated total and fungus-specific serum immunoglobulin E levels
- nih.gov
Pathophysiologically driven by an exaggerated T-helper type 2 inflammatory reaction, the condition is clinically marked by recurrent wheezing, cough with brown mucus plugs, pulmonary infiltrates, peripheral blood and sputum eosinophilia, and elevated total and fungus-specific serum immunoglobulin E levels Without timely recognition, persistent airway inflammation can cause central bronchiectasis and irreversible fibrotic lung damage
Personalize your experience
Follow Allergic bronchopulmonary aspergillosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.